...
首页> 外文期刊>Journal of Microencapsulation: Microcapsules Liposomes Nanoparticles Microcells Microspheres >A novel hydrogel plug of Sterculia urens for pulsatile delivery: in vitro and in vivo evaluation
【24h】

A novel hydrogel plug of Sterculia urens for pulsatile delivery: in vitro and in vivo evaluation

机译:一种用于脉搏传递的新型Sterculia urens水凝胶塞:体外和体内评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objective of this study was to investigate a novel hydrogel plug using isolated root mucilage of Sterculia urens to obtain a desired lag time for an oral chronotherapeutic colon-specific pulsatile drug delivery of indomethacin. Pulsatile drug delivery was developed using chemically treated hard gelatin capsule bodies filled with eudragit multiparticulates of indomethacin, and sealed with different hydrogel plugs (root mucilage of S. urens, xanthan gum, guar gum, HPMC K4M and combination of maltodextrin with guar gum). Indomethacin multiparticulates were prepared using extrusion spheronization, spray drying and solvent evaporation techniques with Eudragit~R L-100 and S-100 (1:2) by varying drug-to-polymer ratio. After oral administration, the water-soluble cap of capsule dissolved in the intestinal fluid and the hydrogel plug swells. After a controlled time, the swollen plug subsequently ejected from the dosage form, releases the contents of the capsule. The formulation factors affecting the drug release were concentration and types of hydrogel plug used. In vivo gamma scintigraphy study in healthy rabbits proved the capability of the system to release drug in lower parts of the gastrointestinal tract after a programmed lag time. This study demonstrates that the indomethacin multiparticulates could be successfully colon-targeted by the design of time and pH-dependent modified chronopharmaceutical formulation. In conclusion, the investigated novel hydrogel plug could be a valuable tool for achieving desired lag time.
机译:这项研究的目的是研究一种新的水凝胶栓塞,该栓塞使用分离的水力发芽的Sterculia urens来获得所需的滞后时间,用于口服消炎痛结肠特异性脉动性药物。使用化学处理的硬明胶胶囊体开发了多药递送,硬胶囊体中填充了吲哚美辛的eudragit多颗粒,并用不同的水凝胶塞(尿链霉菌的根粘液,黄原胶,瓜尔胶,HPMC K4M以及麦芽糊精与瓜尔胶的组合)制成。通过挤出滚圆法,喷雾干燥和溶剂蒸发技术,通过改变药物与聚合物的比例,使用Eudragit®R L-100和S-100(1:2),制备消炎痛多颗粒。口服后,胶囊的水溶性胶囊溶解在肠液中,水凝胶塞膨胀。在控制的时间之后,溶胀的栓塞随后从剂型中弹出,释放出胶囊的内容物。影响药物释放的配方因素是所使用的水凝胶塞的浓度和类型。在健康兔子中进行的体内伽玛闪烁显像研究证明,该系统具有在程序性滞后时间后在胃肠道下部释放药物的能力。这项研究表明消炎痛多颗粒可以通过设计时间和pH依赖的改良年代药物配方而成功地结肠靶向。总之,研究的新型水凝胶塞可能是实现所需滞后时间的有价值的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号